3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 3
2
Phase 1
2
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Neoplasm Metastasis
8
Colorectal Neoplasms
7
Lung Neoplasms
6
Prostatic Neoplasms
5
Melanoma
5
Carcinoma, Hepatocellular
5
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
Multiple Myeloma
4
Fallopian Tube Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Pancreatic Neoplasms
3
Lymphoma, Mantle-Cell
3
Leukemia, Myeloid, Acute
3
Carcinoma, Renal Cell
3
Sarcoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Myelodysplastic Syndromes
2
Meningioma
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Biphenotypic, Acute
2
Glioblastoma
2
Gastrointestinal Neoplasms
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Carcinoma, Merkel Cell
2
Interventions
sargramostim
1
rebastinib
1
pembrolizumab
1
X-Rays
1
Specimen Handling
1
Paclitaxel
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
DCC-2036
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Biopsy
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Carcinosarcoma
×
Specimen Handling
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled